Department of Radiation Oncology
First author Brett Tortelli, MD, PhD, has been mentored by Dr. Julie Schwarz over the past three years as he has been studying the associations between the vaginal microbiome and the response of standard of care chemoradiation in locally advanced cervical cancer.
Julie Schwarz, MD, PhD, presented her research in Paphos, Cyprus on November 1, 2024.
Ana Carolina Paschoalini Mafra, PhD, Postdoc Research Associate in the Schwarz Lab, presented cervical cancer research on November 1, 2024 at the Cancer Research Symposium held at WashU Medicine.
Recognizing exceptional service to radiation oncology & cancer care as a whole, ASTRO professionals recently voted to confer upon Dr. Schwarz the designation of Fellow. She received this in Washington, D.C. in October, 2024, during ASTRO’s 66th Annual Meeting. Shown here in this photo with other female Fellow designees.
“Mono- and diunsaturated fatty acids sensitize cervical cancer to radiation therapy”
Julie Schwarz, MD, PhD, was elected Vice President of the Radiation Research Society and will subsequently become President next year.
Jennifer Stanley, MD, PhD, Holman Pathway resident, has been awarded a Research Resident/Fellow Grant from Radiological Society of North America (RSNA).
She will receive $30,000 to continue her work “Exploiting Radiation Induced Anti-tumor Immunity in Advanced-stage and Metastatic Ovarian Cancer”.
Dr. Fiona Ruiz successfully defended her thesis on Thursday, November 14, 2019.
The Cancer Biology Division had an impressive number of presenters and attendees.
“Altering cellular reducing potential changes 64Cu-ATSM signal with or without hypoxia.”
Cancer Biology Division Director & Associate Professor Dr. Julie Schwarz accepted a 2019 AACR Investigator Grant award to continue her work “Targeting CXCR2 to Improve Radiation Induced Anti-Tumor Immunity”
Immune-boosting compound makes immunotherapy effective against pancreatic cancer Panni RZ, Herndon JM, Zuo C, Hegde S, Hogg GD, Knolhoff BL, Breden MA, Li X, Krisnawan VE, Khan SQ, Schwarz JK, Rogers BE, Fields RC, Hawkins WG, Gupta V, DeNardo DG. Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies. Science Translational Medicine. […]
http://medicine.wustl.edu/news/cutting-off-cervical-cancers-fuel-supply-stymies-tumors/ »
Members of the Schwarz lab were co-authors of an article evaluating the effect of obesity and obesity-associated factors on the outcomes of patients with cervical cancer that was recently published in Oncotarget. Read full article »
Using imaging markers to guide therapeutic options for cancer patients
Fiona Ruiz recently presented her work discussing pre-treatment cervical tumors at the 2017 American Association for Cancer Research (AACR) Conference in Washington, DC.